DV
Dividend Vision

WHWK — Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. (WHWK)

Total return is -95.0% over the past 9 years, 356.3 points behind SPY at 261.3%. Its deepest 1-year drawdown was 28.2%.

Based on the data provided, a comprehensive summary cannot be written at this time. The ETF record appears incomplete, with missing critical information including the fund's objective, underlying holdings, distribution frequency, expense ratio, and assets under management. Whitehawk Therapeutics shows no distribution rate, suggesting it may not be structured as a dividend-focused fund. Additional data would be needed to accurately describe the fund's strategy, income characteristics, and target investor profile.

WHWK key facts

Asset type
Stock
Asset class
Equity
Inception date
08/08/2017
Last close
$4.46
Market cap
$193,359,136
Average volume
274478.0
Beta
0.769
Payout ratio
0.0
Forward P/E
2.661
EPS
$-2.56